In 2025, the Rosalind and Morris Goodman Cancer Institute marked a defining moment with a $10 million gift from the Courtois Foundation and the appointment of Professor John Stagg as its new Director. Together, these developments signal a new era of leadership and momentum for cancer research in Montreal and beyond.
The gift, established as the Joan Courtois Cancer Research Fund—was secured under the leadership of outgoing Director Professor Morag Park and directly enabled the recruitment of Professor Stagg, an internationally recognized leader in cancer immunology. This transformative investment strengthened the GCI’s ability to attract top scientific leadership while supporting innovative research across cancer biology, immunotherapy, and personalized medicine.
As Director, Professor Stagg brings a strong vision for collaboration, innovation, and translating research discoveries into real-world impact. By strengthening partnerships and acceleratinYeag the path from the laboratory to the clinic, his leadership positions the GCI to help shape the future of cancer care.
Together, this philanthropic investment and leadership transition honour a decade of growth while positioning the GCI to shape the next era of cancer research and improve outcomes for patients and families.
Learn more:
John Stagg named Director of the Rosalind and Morris Goodman Cancer Institute